je.st
news
Zacks Investment Research Downgrades Bayer AG (BAYRY) to Hold
2016-01-18 23:52:21| Biotech - Topix.net
According to Zacks, "Bayer's revenues during the third quarter of 2015 were boosted by its newly launched pharmaceutical products. These products are expected to continue their strong run in the upcoming quarters as well.
Tags: research
hold
investment
bayer
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||